Common diabetes pill may shield the brain after stroke
NCT ID NCT07241897
Summary
This study is testing whether a widely used diabetes medication (a DPP4 inhibitor) can help protect memory and thinking skills in people who have had a mild stroke and also have type 2 diabetes. Researchers will give the drug or a placebo to over 300 participants for six months to see if it improves cognitive test scores and reduces the risk of post-stroke cognitive impairment. The goal is to find a safe, existing treatment that could help manage this common and serious complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.